Results 31 to 40 of about 1,054,709 (177)
Embolization in an adrenocortical carcinoma as palliative therapy [PDF]
Background: With an annual incidence of 0.2% of new cases per 100,000 inhabitants, adrenocortical carcinoma is rare. In advanced tumor only palliative treatment modalities are practicable. Because of scarcity of the tumor, standard treatment has not been
Kühl, M. +11 more
core +1 more source
ObjectiveTo investigate the clinicopathological characteristics and long-term survival outcomes of pediatric adrenal malignancies.MethodThis study retrospectively analyzed children with pathologically confirmed pediatric adrenal malignancies from ...
Zemin Lv +6 more
doaj +1 more source
Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R [PDF]
Adrenocortical carcinoma (ACC) is a rare and highly aggressive endocrine neoplasm, with limited therapeutic options. Activating β-catenin somatic mutations are found in ACC and have been associated with a poor clinical outcome. In fact, activation of the
Lucile Lefèvre +35 more
core +1 more source
Retroperitoneoscopic adrenalectomy in an infant with adrenocortical virilizing tumor
CONTEXT: Adrenocortical virilizing tumors are rare in the pediatric age group. Laparoscopic surgery is the gold standard method for treatment of adrenal functional tumors under 6 cm in size, in adults.
Marcos Tobias-Machado +8 more
doaj +1 more source
Li-Fraumeni syndrome: Adrenal cortical tumor in a newborn followed by a choroid plexus tumor
Adrenocortical tumors (ACTs) are rare in children, comprising
Jamie E. Anderson, Rebecca A. Stark
doaj +1 more source
Adrenocortical tumors in children: Sri Lankan experience from a single center, and a mini review
Background Pediatric adrenocortical tumors include both benign adenomas and highly virulent malignant tumors. However, they are very rare among children.
Naotunna Palliya Guruge Chamidri Randika Naotunna +7 more
doaj +1 more source
EDP-mitotane in children: reassuring evidence of reversible side-effects and neurotoxicity
Adrenocortical carcinoma affects one in 5 million children each year. Since prognosis for children older than 4 years is limited, clinicians often choose aggressive treatment with etoposide, doxorubicin, cisplatin (EDP) and mitotane after resection ...
Rebecca V. Steenaard +4 more
doaj +1 more source
Adrenocortical carcinoma: A rare tumor in a 12-year-old girl
A 12-year-old girl presented with intra-abdominal mass and cushingoid features. On investigation, she was diagnosed as a case of functioning adrenocortical carcinoma.
Sandesh V Parelkar +8 more
doaj +1 more source
Unlike other pediatric extra cranial solid neoplasms, neuroblastomas have very low incidence of pulmonary metastases. Neuroblastomas also tend to encase rather than infiltrate the major vessels with very low incidence of tumor thrombus.
Somesh Singh +5 more
doaj +1 more source
Effects of o,p’-DDE, a Mitotane Metabolite, in an Adrenocortical Carcinoma Cell Line
In South Brazil, the incidence of pediatric adrenocortical carcinoma (ACC) is higher than in other regions and countries worldwide. The ACC treatment includes therapy with mitotane, the only adrenolytic drug approved by the FDA.
Camila Bach +4 more
doaj +1 more source

